-
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
21 Dec 2023 04:45 GMT
… lung cancers. The two broad histological subtypes of lung cancer are small cell lung cancer … specifically accumulate in lung tumor tissues, improving drug … targeted delivery to lung tumors is a promising … lung cancer. Von Pawel et al reported that amrubicin, …
-
Could Your Patients Benefit? New Trials in Lung Cancer
20 Sep 2023 13:59 GMT
… advanced non–small cell lung cancer (NSCLC). Adult patients … with this type of lung cancer are eligible for another … clinicaltrials.gov.
Small cell lung cancer (SCLC) relapsed after … Zepzelca), topotecan (Hycamtin), or amrubicin (Calsed) in some countries. …
-
Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects
02 Aug 2023 11:18 GMT
… Keywords: small-cell lung cancer, extensive-stage, … lung cancer (SCLC) accounts for 10–15% of all lung cancers … -cell lung cancer: North Japan Lung Cancer Study … amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients. Transl Lung Cancer …
-
Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases
13 Dec 2022 23:43 GMT
… lung cancer is classified as small cell lung cancer (SCLC) or non–small cell lung cancer … from small cell lung cancer: consequences of changing … III study comparing amrubicin plus cisplatin with irinotecan … in small-cell lung cancer. Clin Lung Cancer. 2008;9(1 …
-
Bristol-Myers Squibb Announces Phase 3 CheckMate -331 Study Does Not Meet Primary Endpoint of Overall Survival with Opdivo Versus Chemotherapy in Patients with Previously Treated Relapsed Small Cell Lung Cancer
12 Oct 2018 12:23 GMT
… amrubicin (where approved), in patients with small cell lung cancer … with relapsed small cell lung cancer (SCLC) following …
About Small Cell Lung Cancer
Lung cancer is the leading cause … lung cancer and accounts for about 10% to 15% of all lung cancers …
-
Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report
22 Feb 2023 19:13 GMT
… (TMB-H). Both lung tumors were stable, and PFS … lung cancer (NSCLC) are two histological subtypes of lung cancer. … lung cancer after treatment of patients with small cell lung cancer (SCLC). Lung Cancer … . The efficacy of amrubicin third-line chemotherapy in …
-
G1 Therapeutics: An Excellent Opportunity In A Underserved Space
26 Sep 2019 17:47 GMT
… in patients with Small Cell Lung Cancer (SCLC). Drugs intended for … for myelopreservation in small cell lung cancer (SCLC). These submissions will … 's (NASDAQ:CELG) Amrubicin, Merck's (NYSE:MRK … treatment of small cell lung cancer. This tells us that …